![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Top Brokers
During the recent discussions on ADVFN regarding Unilever Plc (ULVR), investor sentiment largely focused on the potential acquisition of GlaxoSmithKline (GSK) and its implications for the consumer goods sector. A significant point of interest was the speculative £50 billion offer for GSK, which prompted discussions about the competitive landscape and potential synergies between Unilever and leading healthcare brands. Investors expressed intrigue about how such a move could position Unilever as a more formidable player in the health and wellness market.
Financial highlights from the conversations emphasized the importance of diversification for Unilever amidst ongoing market challenges. Investors are keenly interested in how the integration of healthcare products could enhance revenue streams and profitability, especially given the shifting consumer preferences towards health-centric products. One participant remarked, “Money in the bank means Unilever could leverage this acquisition to strengthen its portfolio,” reflecting a positive sentiment towards strategic expansions in health-related sectors. Overall, discussions suggested a cautious optimism among investors about Unilever’s potential strategic maneuvers in the wake of significant industry developments.
Show more
Unilever PLC has recently announced a significant change to its board of directors, appointing Zoe Yujnovich, a seasoned executive from Shell, as an independent Non-Executive Director. Yujnovich, who currently serves as Shell's Integrated Gas and Upstream Director, will officially join the Unilever Board on March 1, 2025. Her extensive background includes a notable tenure at Rio Tinto, where she held various leadership roles, including President and CEO of the Iron Ore Company of Canada. Yujnovich's experience in navigating large-scale transformations and her extensive network in global business and regulatory environments are expected to bolster Unilever's corporate governance.
Additionally, Unilever provided an update on its voting rights and capital structure, disclosing that as of January 31, 2025, the company had issued capital comprising 2,524,997,338 ordinary shares, with 2,475,622,719 shares attached to voting rights. This data is crucial for shareholders in assessing their stakes in the company, particularly in light of upcoming changes in governance and strategic direction. The recent developments indicate Unilever's ongoing efforts to enhance its leadership and align its corporate governance with the evolving business landscape.
Show more
5000 pence milestone coming into view now, maybe next week when the DRIP from the latest payout gets rolled back in again.. |
LLB, yes for sure. In the box with SHEL and AZN ;-) |
#Philanderer, another keep for life share this one IMO and wait for the dividend growth to come, premium/luxury has had a tough ride, but for all the reasons in your article I continue to hold here, and plan to add again on new ISA day next year.. :o) |
The Telegraph |
Unilever trialling use of unwanted flowers to make fragrances for products |
Unilever slims skincare portfolio with Kate Somerville sale |
Strange that Peltz trimmed though |
#Philanderer, thanks, I wondered what todays share price catalyst was.. :o) |
Bank of America raises Unilever to 'buy' (underperform) - price target 5,600 (3,800) pence |
Thanks Phil... Some food for thought |
Activist investor Nelson Peltz trims stake in Marmite-owner Unilever |
KENNEWIL : To use the title you quote from the Guardian article, yes - companies like Unilever ARE free to choose where they advertise.... |
Relying on a finance journo with the surname Pratley with regard to US legal matters is definitely a leap of faith. |
https://www.theguard |
The chart look s better for a pull back, much the same as BATS does after some strong gains, how long to 5000 here, quite a milestone, but it is now in sight again after late 2019.. :o) |
Given how woke the former leadership was reputed to be, they may just settle after a few legal shenanigans. |
Nice balance LLB - the headlines are always sadly lacking in that. |
Unlikely to succeed, and applies to Mars and others, they can spend their advertising budget where they like and are not tied to any one platform or Twitter..? |
Unilever is being hit with a anti-trust lawsuit by X (formerly Twitter).https://x.c |
It would be a bit unprecedented for Unilever to trade 24x earnings. A comparison with European staplers would be more appropriate. I doubt unileve rhad the same quality brands as praocter and gamble (e.g. Gillette, head and shoulders, pampers, Oley etc.) |
From Investors Chronicle Consumer staples giants Reckitt Benckiser (RKT) and Unilever (ULVR) are both attempting to divest from underperforming business areas as they focus on their top "power brands" in a bid to build market share, cut costs and fend off investor pressure.Last week, Reckitt announced plans to streamline operations and focus on a "high-growth, high-margin" core brand portfolio which delivered a 61 per cent gross margin in 2023 and a five-year like-for-like net revenue compound annual growth rate of 7 per cent.It aims to sell a portfolio of home care brands, including Air Wick, Mortein, Calgon and Cillit Bang, which contributed 13 per cent of net revenue last year. It is also examining "all strategic options" around its infant formula nutrition business Mead Johnson, which suggests a sale of the struggling unit it acquired for $17bn (£13bn) in 2017. The subsidiary posts almost a fifth of the company's net revenue.The fresh strategy under new chief executive Kris Licht is similar to the transformation plan at Unilever. Boss Hein Schumacher, who like Licht took the reins last year, is spearheading a growth plan which focuses on the company's 30 biggest brands. In the latest half, these contributed three-quarters of revenue and outperformed the rest of the business on underlying sales and volume growth. Unilever is also trying to split off its ice cream business, its smallest unit which delivers 15 per cent of revenue between brands Wall's, Magnum and Ben & Jerry's.Both companies have also taken the axe to employee numbers. Reckitt is aiming to cut its fixed cost base from 22 per cent to 19 per cent of net revenue, while Unilever is slashing 7,500 jobs and has guided for $800mn of cost reductions over three years. Restructuring charges are guided to come in £1bn in the three years to 2027 at Reckitt, and 1.2 per cent of revenue this year at Unilever.Plan potentialReckitt is the higher-margin business, which is the context in which Unilever's goal of achieving "a structurally higher margin" must be seen. For the six months to 30 June, Reckitt recorded an underlying operating margin of 24 per cent and gross margin of 61 per cent, compared to 20 per cent and 46 per cent, respectively, at its competitor.But the big question mark over Reckitt's strategy comes from ongoing legal headaches at Mead Johnson. Reckitt's shares were hit this week after infant formula rival Abbott Laboratories (US:ABT) lost a $500mn court case in Missouri over allegations it refused to warn that its products can cause the necrotising enterocolitis (NEC) bowel disease. Reckitt lost a $60mn case in Illinois on the issue in March, and more cases are incoming. It is increasingly uncertain if there will be interested buyers queuing up for the division.Analysts at Jefferies estimated that Reckitt's share price "is already discounting for $3.5bn of liability risk" for NEC issues in 2025. But with an NEC trial involving Reckitt kicking off in Missouri in September and multidistrict litigation (MDL) action building up, "that risk may be extended".By contrast, the removal of Unilever's ice cream arm is more straightforward, and would take out a low-margin part of the business which has caused internal legal headaches through subsidiary Ben & Jerry's attempts to stop sales in Israel. It could also help boost underlying sales growth to the higher end of management's 3-5 per cent target range, given the unit's relatively weak performance.Unilever reported a 420 basis point rise in gross margin alongside an increase to annual underlying operating margin guidance in its first half, and boosted brand investment ahead of peers, but margin recovery looks more difficult in the near-term.Analysts at Berenberg said that "while execution remains key [including innovation activity], we think that the recovery in US prestige beauty, easing competition in China, better weather in Europe and easing boycotts on western brands in Indonesia" could boost the company's growth next year.The new strategies come as price hike rates slow across consumer staples as inflation subsides. Nestlé (CH:NESN) said this week that price growth of 2 per cent in its half-year results had come "down faster than expected". Unilever's underlying price growth of 1 per cent in its second quarter was similarly lower than expected by analysts.ValuationsU |
Sh*t I sold at £47.5. |
25.07.2024 - in March we announced the separation of Ice Cream and the launch of a major productivity programme to strengthen the company and substantially improve our efficiency and effectiveness. Separation activity is underway and on track to complete by the end of 2025. We are working at pace on the legal entity set up, the standalone operating model and carve-out financials. In July, we communicated internally on the planned changes to simplify our business and further evolve our category-focused operating model. We have started consultations with the respective works councils. |
Type | Ordinary Share |
Share ISIN | GB00B10RZP78 |
Sector | Perfume,cosmetic,toilet Prep |
Bid Price | 4,720.00 |
Offer Price | 4,721.00 |
Open | 4,695.00 |
Shares Traded | 5,086,512 |
Last Trade | 16:35:16 |
Low - High | 4,688.00 - 4,737.00 |
Turnover | 59.6B |
Profit | 6.49B |
EPS - Basic | 2.6204 |
PE Ratio | 18.01 |
Market Cap | 116.3B |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions